ICICI Direct has sell call on with a target price of Rs 700. The current market price of Aurobindo Pharma is Rs 715.65. Time period given by analyst is intraday when Aurobindo Pharma price can reach defined target.
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 41923.91 Crore) operating in Pharmaceuticals sector.
Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Scrap and Sale of services for the year ending 31-Mar-2021.
For the quarter ended 30-06-2021, the company reported a Consolidated Total Income of Rs 5783.29
Crore, down -4.87 % from last quarter Total Income of Rs 6079.60 Crore and down -4.26 % from last year same quarter Total Income of Rs 6040.37 Crore. Company reported net profit after tax of Rs 778.97 Crore in latest quarter.
Price reacting lower facing resistance at previous highs & 20 day EMA
Promoters held 51.8 per cent stake in the company as of June 30, 2021, while FIIs held 23.7 per cent, DIIs 14.7 per cent and public and others 9.8 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.